Minims Cyclopentolate Hydrochloride 1,0 % 0,5 ml Eye drops,
PDF Leaflet Revision Date: 28 March 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Mydriasis and cycloplegia for iridocyclitis and applanation tonometry.
Dosage (summary)
Adults: 1 drop for refraction, repeat after 5 mins; for iridocyclitis: 1 drop every 6-8 hours. Children: 1 drop, observe for 45 mins.
Onset of Action / Duration
Onset: 30-60 mins, Duration: 24 hours
Special Populations
- Elderly
- Children under 1 year
- Patients with CNS disorders
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Antiglaucoma agents (carbachol, pilocarpine)
- Ophthalmic cholinesterase inhibitors
Contraindications
- Hypersensitivity to cyclopentolate
- Narrow-angle glaucoma
- Neonates
- Sensitive patients (e.g., infants, elderly)
Common side effects
- Local irritation
- Increased intraocular pressure
- CNS disturbances
Counselling Points
- Avoid driving until vision is clear
- Protect eyes from light
- Do not administer to children under 1 year
Serious warnings
- Risk of systemic toxicity in children
- Caution in angle closure glaucoma
Important Disclaimer
The Minims Cyclopentolate Hydrochloride 1,0 % 0,5 ml Eye drops, professional information leaflet below is the property of Soflens and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
